First Tracks Bio

First Tracks Bio is a pre-clinical stage biotechnology company headquartered in Seattle, Washington, dedicated to developing transformative therapies for oncology. The company was founded and is currently being incubated by ARCH Venture Partners, utilizing a team of seasoned industry executives and scientific pioneers. First Tracks Bio focuses on the tumor microenvironment and novel immuno-oncology pathways to create precision medicines for patients with significant unmet needs. While the company maintains a low public profile, its leadership includes prominent figures from the Fred Hutchinson Cancer Center and the venture capital community. The firm is currently advancing a pipeline of biologic candidates aimed at overcoming resistance in solid tumors.